drugset / Trial / NCT05160220
Naturalistic Study of Microdosing With Psilocybin
RandomizedSingle-groupDouble-blindBasic science
Summary
This study seeks to understand the neural, cognitive and behavioral effects of low doses of psilocybin administered in the form of dried mushroom material (0.5 g of Psilocybe cubensis) consumed in natural settings following a placebo-controlled double-blind experimental design.
Timeline
- Start
- 2021-01-20
- Primary completion
- 2021-06-30
- Completion
- 2021-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Psilocybin | Other / unclassified | 0.8 mg | — |
Indications
No indication recorded.